{
    "organizations": [],
    "uuid": "854f233253a3fdc7b0d263d33b4b48c3101993f7",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-tianjin-zhongxin-pharmaceutical-sa/brief-tianjin-zhongxin-pharmaceutical-says-fy-profit-net-of-tax-attributable-rmb476-1-million-idUSFWN1RB11E",
    "ord_in_thread": 0,
    "title": "BRIEF-Tianjin Zhongxin Pharmaceutical Says FY Profit Net Of Tax Attributable Rmb476.1 Million",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 30 (Reuters) - Tianjin Zhongxin Pharmaceutical Group Corp Ltd:\n* FY REVENUE RMB5.69 BILLION VERSUS RMB6.24 BILLION * FY PROFIT NET OF TAX ATTRIBUTABLE RMB476.1 MILLION VERSUS RMB423.6 MLN‍​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-03-30T17:38:00.000+03:00",
    "crawled": "2018-03-31T19:12:05.001+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "tianjin",
        "zhongxin",
        "pharmaceutical",
        "group",
        "corp",
        "ltd",
        "fy",
        "revenue",
        "billion",
        "versus",
        "billion",
        "fy",
        "profit",
        "net",
        "tax",
        "attributable",
        "million",
        "versus",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}